224 related articles for article (PubMed ID: 25318351)
1. Use of panel tests in place of single gene tests in the cancer genetics clinic.
Yorczyk A; Robinson LS; Ross TS
Clin Genet; 2015 Sep; 88(3):278-82. PubMed ID: 25318351
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of laboratory perspectives on hereditary cancer panels.
Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ
Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169
[TBL] [Abstract][Full Text] [Related]
3. Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice.
Doherty J; Bonadies DC; Matloff ET
J Genet Couns; 2015 Aug; 24(4):683-7. PubMed ID: 25475920
[TBL] [Abstract][Full Text] [Related]
4. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
[TBL] [Abstract][Full Text] [Related]
5. Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories.
Rosenthal ET; Bernhisel R; Brown K; Kidd J; Manley S
Cancer Genet; 2017 Dec; 218-219():58-68. PubMed ID: 29153097
[TBL] [Abstract][Full Text] [Related]
6. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
[TBL] [Abstract][Full Text] [Related]
7. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
[TBL] [Abstract][Full Text] [Related]
8. Application of Panel-Based Tests for Inherited Risk of Cancer.
Shah PD; Nathanson KL
Annu Rev Genomics Hum Genet; 2017 Aug; 18():201-227. PubMed ID: 28504904
[TBL] [Abstract][Full Text] [Related]
9. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.
Ricker C; Culver JO; Lowstuter K; Sturgeon D; Sturgeon JD; Chanock CR; Gauderman WJ; McDonnell KJ; Idos GE; Gruber SB
Cancer Genet; 2016 Apr; 209(4):130-7. PubMed ID: 26908360
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.
Chang EY; Solomon I; Culver JO; Gorman N; Comeaux JG; Lerman C; Quinn EA; Ekstein T
J Genet Couns; 2023 Jun; 32(3):706-716. PubMed ID: 36747331
[TBL] [Abstract][Full Text] [Related]
11. Clinical genetic testing in pediatric cardiomyopathy: Is bigger better?
Ouellette AC; Mathew J; Manickaraj AK; Manase G; Zahavich L; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Jan; 93(1):33-40. PubMed ID: 28369760
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing today.
Euhus D
Ann Surg Oncol; 2014 Oct; 21(10):3209-15. PubMed ID: 25029991
[TBL] [Abstract][Full Text] [Related]
13. How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing.
Pilarski R
J Natl Compr Canc Netw; 2021 Jan; 19(1):103-108. PubMed ID: 33406496
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
[TBL] [Abstract][Full Text] [Related]
15. Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice.
Selkirk CG; Vogel KJ; Newlin AC; Weissman SM; Weiss SM; Wang CH; Hulick PJ
Fam Cancer; 2014 Dec; 13(4):527-36. PubMed ID: 25117502
[TBL] [Abstract][Full Text] [Related]
16. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
17. Researchers Find Discrepancies in Gene Panel Tests for Cancer.
Schmidt C
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 30053095
[No Abstract] [Full Text] [Related]
18. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
Reuter C; Chun N; Pariani M; Hanson-Kahn A
J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
[TBL] [Abstract][Full Text] [Related]
19. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
20. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
